Theravance Biopharma Inc (TBPH) Sof marja

Theravance Biopharma, Inc. (TBPH) kompaniyasining rasmiy ramzlari

Sotuv marjasi dinamikasi Theravance Biopharma (TBPH) tasdiqlangan dori vositalaridan foyda olish va o'z majburiyatlarini qayta tuzish yo'nalishida o'tish qilayotganini tasdiqlaydi. Ushbu ko'rsatkichlarning barqarorligi elastik bo'lmagan talabga va dori vositalarining a'zo-selektivligiga, shuningdek, distribyutsiya bo'yicha sanoat gigantlari bilan tuzilgan strategik ittifoqlarga asoslangan. Ushbu ko'rsatkichning joriy darajasi 51.60 bo'lib, bu tushumni sof foydaga aylantirish samaradorligini ko'rsatadi.

theravance.com (TBPH) - Sotuvning sof marjinal rentabelligi 04.07.2022dan 10.10.2026gacha

TBPH (Theravance Corp): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- aksiya kursi va ekspertlarning narx prognozi:
Kompaniyaning jamlanma tahlili:Theravance Biopharma Inc - TBPH
Theravance yetakchi tovari

Respirator patologiyalarini davolash uchun selektiv dori vositalarini ishlab chiquvchi Theravance Biopharma (TBPH) uchun sof operatsion marja innovatsiyalarni monetizatsiya qilish samaradorligining ko'rsatkichi bo'lib xizmat qiladi. Ushbu metrika sof foydaning umumiy daromadga nisbati sifatida hisoblanadi, bu esa investorlarga spekulyativ shovqinlarni filtrlash va uzoq muddatli kapital barqarorligini hamda biznesning operatsion rentabelligini tasdiqlovchi haqiqiy foyda ulushini baholash imkonini beradi.

Asosiy raqobatchilar

HLN: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi KVUE|Sof marja veronapharma.com|Sotuvning sof rentabelligi MENS (Jyong Biotech Corp)|Sof marja Ligand (LGND)|Sotuvning sof marjinal rentabelligi amneal.com (AMRX)|Sotuvning sof marjinal rentabelligi PRGO (perrigo.com)|Alvotech SA (ALVO) - Sof marja|Liquidia Inc. - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha marjinallik Galapagos Corp (GLPG)|ANI Pharmaceuticals (ANIP) - Sof marja|Sotuvning sof rentabelligi MNKD|Sof marja Amphastar Pharmaceuticals, Inc.|Pacira Pharmaceuticals (PCRX) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi SPRY|AQST (Aquestive Therapeutics) - Sof foyda normasi|scPharmaceuticals, Inc. - Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi TECX|tonixpharma.com - Sotuvning sof marjinal rentabelligi|Sof foyda normasi SXTC (sxtchina.com)|Eupraxia Pharma (EPRX) - Sof marja|Sof foyda bo'yicha sotuv rentabelligi BioHarvest|Sof foyda bo'yicha sotuv rentabelligi EXOZ|Sof foyda bo'yicha sotuv rentabelligi Oramed Pharmaceuticals (ORMP)|Sof foyda bo'yicha sotuv rentabelligi ENTX (Entera Bio Corp)|MindWalk Holdings Inc. - Sotuvning sof rentabelligi|Sotuvning sof marjinal rentabelligi ABVC (ABVC BioPharma Inc)|CPIX - Sof foyda bo'yicha sotuv rentabelligi|Quantum BioPharma Corp - Sotuvning sof marjinal rentabelligi|FGEN (fibrogen.com) - Sotuvning sof rentabelligi|TELO (Telomir Pharmaceuticals) - Sof foyda bo'yicha sotuv rentabelligi|Rani Therapeutics Holdings - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi SNYR|Sof marja rallybio.com RLYB|Sotuvning sof marjinal rentabelligi LEXX|PULM (Pulmatrix, Inc.) - Sof foyda normasi|Pheton Holdings - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi Aptorum Group Limited APM|LYRA: Sof foyda bo'yicha sotuv rentabelligi|IBO: Sof marja|TNFA: Sotuvning sof marjinal rentabelligi|YCBD: Kompaniyaning sof rentabelligi|Sof marja PainReform Ltd|CYTO (altamiratherapeutics.com) - Kompaniyaning sof rentabelligi|Sotuvning sof marjinal rentabelligi LIPO|OPTN - Sof marja|Sof marja pieris.com PIRS|Sof foyda normasi PROC|PTPI - Sof marja|Qilian International Holding (QLI) - Sof foyda bo'yicha sotuv rentabelligi|SLRN: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi TFF Pharma